SCRI Teams Up With Merck to Boost Oncology Clinical Trials

SCRI's latest collaboration aims to accelerate patient access and enrollment in oncology clinical trials. The strategic partnership with Merck will leverage SCRI's integrated trial delivery model, Accelero, to streamline operations and bring cutting-edge research closer to patients' homes.

This collaboration combines the expertise of SCRI, as part of McKesson Oncology and Multispecialty, with industry-leading operational infrastructure. By working together, the two organizations aim to make clinical trials more efficient and accessible for patients.